125 related articles for article (PubMed ID: 29333130)
21. Mutant p53R273H attenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high levels of reactive oxygen species.
Kalo E; Kogan-Sakin I; Solomon H; Bar-Nathan E; Shay M; Shetzer Y; Dekel E; Goldfinger N; Buganim Y; Stambolsky P; Goldstein I; Madar S; Rotter V
J Cell Sci; 2012 Nov; 125(Pt 22):5578-86. PubMed ID: 22899716
[TBL] [Abstract][Full Text] [Related]
22. CPe-III-S Metabolism in Vitro and in Vivo and Molecular Simulation of Its Metabolites Using a p53-R273H Mutant.
Xue Z; Wen H; Wang C; Zhai L; Cheng A; Kou X
J Agric Food Chem; 2016 Sep; 64(38):7095-103. PubMed ID: 27584867
[TBL] [Abstract][Full Text] [Related]
23. Ranking the Binding Energies of p53 Mutant Activators and Their ADMET Properties.
Omar SI; Tuszynski J
Chem Biol Drug Des; 2015 Aug; 86(2):163-72. PubMed ID: 25407396
[TBL] [Abstract][Full Text] [Related]
24. The R273H p53 mutation can facilitate the androgen-independent growth of LNCaP by a mechanism that involves H2 relaxin and its cognate receptor LGR7.
Vinall RL; Tepper CG; Shi XB; Xue LA; Gandour-Edwards R; de Vere White RW
Oncogene; 2006 Mar; 25(14):2082-93. PubMed ID: 16434975
[TBL] [Abstract][Full Text] [Related]
25. SW480, a p53 double-mutant cell line retains proficiency for some p53 functions.
Rochette PJ; Bastien N; Lavoie J; Guérin SL; Drouin R
J Mol Biol; 2005 Sep; 352(1):44-57. PubMed ID: 16061257
[TBL] [Abstract][Full Text] [Related]
26. Mutant p53 perturbs DNA replication checkpoint control through TopBP1 and Treslin.
Liu K; Lin FT; Graves JD; Lee YJ; Lin WC
Proc Natl Acad Sci U S A; 2017 May; 114(19):E3766-E3775. PubMed ID: 28439015
[TBL] [Abstract][Full Text] [Related]
27. The apoptotic and transcriptional transactivation activities of p53 can be dissociated.
Bissonnette N; Wasylyk B; Hunting DJ
Biochem Cell Biol; 1997; 75(4):351-8. PubMed ID: 9493957
[TBL] [Abstract][Full Text] [Related]
28. Modulation of wild-type p53 activity by mutant p53 R273H depends on the p53 responsive element (p53RE). A comparative study between the p53REs of the MDM2, WAFI/Cip1 and Bax genes in the lung cancer environment. WAFI/Cip1 = WAF1/Cip1.
Zacharatos PV; Gorgoulis VG; Kotsinas A; Manolis EN; Liloglou T; Rassidakis AN; Kanavaros P; Field JD; Halazonetis T; Kittas C
Anticancer Res; 1999; 19(1A):579-87. PubMed ID: 10226602
[TBL] [Abstract][Full Text] [Related]
29. p53-R273H promotes cancer cell migration via upregulation of neuraminidase-1.
Lv T; Lv H; Fei J; Xie Y; Lian D; Hu J; Tang L; Shi X; Wang J; Zhang S; Li F; Jiang X; Yi Y
J Cancer; 2020; 11(23):6874-6882. PubMed ID: 33123278
[TBL] [Abstract][Full Text] [Related]
30. Abrogation of wild-type p53-mediated transactivation is insufficient for mutant p53-induced immortalization of normal human mammary epithelial cells.
Cao Y; Gao Q; Wazer DE; Band V
Cancer Res; 1997 Dec; 57(24):5584-9. PubMed ID: 9407971
[TBL] [Abstract][Full Text] [Related]
31. MPK-09, a small molecule inspired from bioactive styryllactone restores the wild-type function of mutant p53.
Metri PK; Naz S; Kondaiah P; Prasad KR
ACS Chem Biol; 2013 Jul; 8(7):1429-34. PubMed ID: 23621494
[TBL] [Abstract][Full Text] [Related]
32. Zn(II)-curc targets p53 in thyroid cancer cells.
Garufi A; D'Orazi V; Crispini A; D'Orazi G
Int J Oncol; 2015 Oct; 47(4):1241-8. PubMed ID: 26314369
[TBL] [Abstract][Full Text] [Related]
33. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin.
Tsvetkov P; Asher G; Reiss V; Shaul Y; Sachs L; Lotem J
Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5535-40. PubMed ID: 15809436
[TBL] [Abstract][Full Text] [Related]
35. Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53.
Bargonetti J; Reynisdóttir I; Friedman PN; Prives C
Genes Dev; 1992 Oct; 6(10):1886-98. PubMed ID: 1398068
[TBL] [Abstract][Full Text] [Related]
36. p53 induces distinct epigenetic states at its direct target promoters.
Vrba L; Junk DJ; Novak P; Futscher BW
BMC Genomics; 2008 Oct; 9():486. PubMed ID: 18922183
[TBL] [Abstract][Full Text] [Related]
37. Identification of ANKRD11 as a p53 coactivator.
Neilsen PM; Cheney KM; Li CW; Chen JD; Cawrse JE; Schulz RB; Powell JA; Kumar R; Callen DF
J Cell Sci; 2008 Nov; 121(Pt 21):3541-52. PubMed ID: 18840648
[TBL] [Abstract][Full Text] [Related]
38. Mutants of the tumour suppressor p53 L1 loop as second-site suppressors for restoring DNA binding to oncogenic p53 mutations: structural and biochemical insights.
Merabet A; Houlleberghs H; Maclagan K; Akanho E; Bui TT; Pagano B; Drake AF; Fraternali F; Nikolova PV
Biochem J; 2010 Mar; 427(2):225-36. PubMed ID: 20113312
[TBL] [Abstract][Full Text] [Related]
39. Heat-shock factor 1 both positively and negatively affects cellular clonogenic growth depending on p53 status.
Nguyen CH; Lang BJ; Chai RC; Vieusseux JL; Kouspou MM; Price JT
Biochem J; 2013 Jun; 452(2):321-9. PubMed ID: 23510323
[TBL] [Abstract][Full Text] [Related]
40. Autophagy Regulated by Gain of Function Mutant p53 Enhances Proteasomal Inhibitor-Mediated Cell Death through Induction of ROS and ERK in Lung Cancer Cells.
Saini H; Hakeem I; Mukherjee S; Chowdhury S; Chowdhury R
J Oncol; 2019; 2019():6164807. PubMed ID: 30723502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
